PROFOUND MEDICAL CORP. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (1 lists). Names and jurisdictions are as filed.
- 2025-03-07: Subsidiary Name Subsidiary; Jurisdiction Jurisdiction.
- 2025-03-07: Subsidiary Profound Medical Inc.; Jurisdiction Canada.
- 2025-03-07: Subsidiary 2753079 Ontario Inc.; Jurisdiction Canada.
- 2025-03-07: Subsidiary Profound Medical Oy; Jurisdiction Finland.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2025-03-07 | Name Subsidiary | Jurisdiction |
| 2025-03-07 | Profound Medical Inc. | Canada |
| 2025-03-07 | 2753079 Ontario Inc. | Canada |
| 2025-03-07 | Profound Medical Oy | Finland |
| 2025-03-07 | Profound Medical Technology Services (Beijing) Co., Ltd. | China |
| 2025-03-07 | Profound Medical GmbH | Germany |
| 2025-03-07 | Profound Medical (U.S.) Inc. | United States |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |